A Study Assessing Optimal Sequence Of Abiraterone And Enzalutamide In Patients With Castration-Resistant Prostate Cancer.
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2017
At a glance
- Drugs Abiraterone (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 21 Mar 2017 New trial record
- 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium.